The document provides a detailed account of federal rules, regulations, and executive orders that were either revoked, paused, or placed under review following the January 20, 2021, Regulatory Freeze Pending Review Presidential Memorandum, issued at the start of the Biden administration. Major actions included the revocation of prior executive orders such as EO 13950, which addressed race and sex stereotyping, and other administration rules relating to federal regulations and agency guidance. Specifically, several Department of Health and Human Services (DHHS) rules involving research, transparency, and administrative practices were revoked or their effective dates postponed pending further review. Similarly, proposed modifications to HIPAA, documentation requirements for foreign gifts in education, Department of Energy procedures, DEA registration processes, and H-1B visa wage regulations were either paused or postponed for reassessment under new leadership.
In addition, proclamations addressing broader equity—such as ending entry bans for certain countries—and policies to preserve DACA were enacted. Some recommendations and memoranda from the Office of Science & Technology Policy relating to research security were noted as likely under review but not subject to the freeze. The chart also referenced pending revisions concerning federal research and inventions from the National Institute of Standards & Technology, as well as the delay of the establishment of a domestic hemp production program by the USDA. The purpose of this comprehensive overview is to inform stakeholders about the status of significant federal regulatory changes during the initial months of the Biden administration, particularly emphasizing those measures halted to allow for policy reconsideration and alignment with new executive priorities.
